Evidence map›Paper›PMID 40458847›Full record

ArticleCurrent protocols2025

Peptide-Oligonucleotide Conjugates: Catalytic Preparation in Aqueous Solution or On-Column.

Marion Gras, Michael Smietana, Pauline Adler

Abstract read
In one paragraph

Article in Current protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Marion GrasIBMM, Université de Montpellier, CNRS, ENSCM, Montpellier, France.ORCID https://orcid.org/0000-0001-6780-2532
Michael SmietanaIBMM, Université de Montpellier, CNRS, ENSCM, Montpellier, France.ORCID https://orcid.org/0000-0001-8132-7221
Pauline AdlerIBMM, Université de Montpellier, CNRS, ENSCM, Montpellier, France.ORCID https://orcid.org/0000-0003-0750-3391

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peptide-oligonucleotide conjugates (POCs) are synthesized through a novel catalytic and sustainable approach. The amide coupling between peptide and oligonucleotide is facilitated by 1,4-diazabicyclo[2.2.2]octane (DABCO) as catalyst and 2-chloro-4,6-dimethoxy-1,3,5-triazine (CDMT) as a stoichiometric activating agent. Two distinct methods are described for the POC synthesis: the first involves an on-column conjugation in an anhydrous environment, while the second enables a post-synthetic conjugation in an aqueous buffer. This last approach has been successfully extended to an iterative process, offering significant potential for the development of DNA-encoded libraries.© 2025 The Author(s). Current Protocols published by Wiley Periodicals LLC. Basic Protocol 1: On-column conjugation of an amino acid or of a peptide to an oligonucleotide Support Protocol: Deprotection of the Boc-protected amine of the lysine Basic Protocol 2: In-solution conjugation of an amino acid or of a peptide on an oligonucleotide Basic Protocol 3: Iterative process for the preparation of a peptide-oligonucleotide conjugate.

Indexed as

OligonucleotidesPeptidesCatalysisSolutionsTriazinesWaterOligonucleotidesPeptidesSolutionsTriazinesWateramide couplingaqueous solutioniterationpeptide–oligonucleotide conjugatessupported synthesis

Identifiers

PMID40458847
PMCPMC12131121

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.